Literature DB >> 7959642

Evaluation of a histogenetic classification for thymic epithelial tumours.

F C Ho1, K H Fu, S Y Lam, S W Chiu, A C Chan, H K Müller-Hermelink.   

Abstract

We reviewed 87 thymic epithelial tumours from Chinese patients and typed them according to the Marino and Müller-Hermelink classification as updated by Kirschner and Müller-Hermelink in 1989. Related categories were grouped for statistical analyses: group 1, medullary thymoma and mixed thymoma; group 2, cortical predominant thymoma; group 3, cortical thymoma and well-differentiated thymic carcinoma; group 4, other thymic carcinomas; and group 5, unclassified. Group 3 tumours were more frequently associated with the myasthenia gravis syndrome compared with group 1 tumours (P = 0.001). They also presented at a more advanced stage. Groups 1 and 2 showed an excellent prognosis (100% survival at 10 years). The 10-year survival for groups 3 and 4 patients was 40% and 30% respectively. Pure medullary thymoma made up a higher proportion of our cases (10.3%) than those of a similar Caucasian study (5.3%). The eight thymic carcinomas (group 4) included two thymic lymphoepitheliomas. We conclude that the histogenetic classification evaluated shows a clear correlation with prognosis and clinical features, even when tested on separate geographic groups, where pathogenetic factors may be different. A common approach to classification of thymic epithelial tumours would greatly facilitate future studies on these possible differences.

Entities:  

Mesh:

Year:  1994        PMID: 7959642     DOI: 10.1111/j.1365-2559.1994.tb00594.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  The World Health Organization (WHO) histologic classification of thymomas: a reanalysis.

Authors:  Cesar A Moran; Saul Suster
Journal:  Curr Treat Options Oncol       Date:  2009-02-04

2.  Neoplastic transformation and angiogenesis in the thymus of transgenic mice expressing SV40 T and t antigen under an L-pyruvate kinase promoter (SV12 mice).

Authors:  Bernadette Nabarra; Christiane Pontoux; Cecile Godard; Mary Osborne-Pellegrin; Sophie Ezine
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

3.  Epithelial thymic tumours in paediatric age: a report from the TREP project.

Authors:  Elena Carretto; Alessandro Inserra; Andrea Ferrari; Massimo Conte; Andrea Di Cataldo; Roberta Migliorati; Giovanni Cecchetto; Gianni Bisogno
Journal:  Orphanet J Rare Dis       Date:  2011-05-21       Impact factor: 4.123

4.  Thymic epithelial tumors can develop along two different pathogenetic pathways.

Authors:  R Zhou; A Zettl; P Ströbel; K Wagner; H K Müller-Hermelink; S Zhang; A Marx; P Starostik
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

5.  Clinical and pathologic predictors of survival in patients with thymoma.

Authors:  K B Wilkins; E Sheikh; R Green; M Patel; S George; M Takano; M Diener-West; J Welsh; S Howard; F Askin; G B Bulkley
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

Review 6.  Juan Rosai as master of our comprehensive understanding of thymus and thymoma.

Authors:  Mirella Marino; Alexander Marx; Lucia Anemona; Libero Lauriola; Philipp Ströbel; Hans Konrad Müller-Hermelink
Journal:  Pathologica       Date:  2021-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.